| Application no. and date | 12764885.5 (espacenet) (Federated) (European Patent Register), 20120330 | | Patent/reg. no. and date | DK/EP 2694106, 20171213 | | Publication date | 20140212 | | Priority no. and date | US 201161471007 P, 20110401 | | EP pub. no. and date |
EP 2694106 20140212 | | Effective date | | | Applicant/owner | ImmunoGen, Inc., 830 Winter Street
Waltham, MA 02451, US | | Applicant ref. no. | P63833DK01 | | Inventor | PAYNE, Gillian, 21 Oak Vale Road
Waban, MA 02468, US,
WHITEMAN, Kathleen, R., 512 Shawsheen Avenue
Wilmington, MA 01887, US,
LADD, Sharron, 9970 Joslin Lake Road
Gregory, MI 48137-9766, US,
CARRIGAN, Christina, N., 4003 24th St., Apt.3
San Francisco, CA 94114, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 39/395 (2006.01) | | Title | FREMGANGSMÅDER TIL ØGET VIRKNING AF FOLR1-CANCERTERAPI | | Int. application no. | US2012031544 | | Int. publication no. | WO2012135675 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
